BenevolentAI
An AI-powered drug discovery platform accelerating R&D for scientists and pharmaceutical partners.
BAI | AS
Overview
Corporate Details
- ISIN(s):
- LU2355630455
- LEI:
- 2221003P54KEDC3P4Z33
- Country:
- United Kingdom
- Address:
- 4-8 Maple Street, W1T 5HD London
- Website:
- https://www.benevolent.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
BenevolentAI is a drug discovery company specializing in the development and application of artificial intelligence for scientific innovation. The company's platform provides life science intelligence to scientists and pharmaceutical executives, leveraging a proprietary knowledge graph and machine learning models to analyze complex biomedical data. Its core mission is to accelerate the research and development process by identifying novel drug targets and understanding disease mechanisms. The technology aims to lower costs, decrease failure rates, and increase the speed of bringing new medicines to market. BenevolentAI collaborates with pharmaceutical partners and develops its own in-house drug portfolio.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-03-12 12:12 |
Delisting Announcement
BAI EGM Results APPROVED
|
English | 169.9 KB | ||
| 2025-02-06 07:00 |
Delisting Announcement
Merger-Delisting and Notice of EGM FINAL APPROVED copy
|
English | 95.2 KB | ||
| 2024-12-11 13:17 |
Delisting Announcement
BenevolentAI unveils major strategic overhaul with return to original mission
|
English | 440.5 KB | ||
| 2024-12-11 07:00 |
Delisting Announcement
241211_BenevolentAI Statement_FINAL
|
English | 440.5 KB | ||
| 2024-12-03 13:36 |
Share Issue/Capital Change
Regulatory Announcement - Issue of Equity and TVR (RSU Settlement) 03122024
|
English | 111.3 KB | ||
| 2024-10-17 07:00 |
Board/Management Information
241017 BenevolentAI_Leadership update_Final
|
English | 384.6 KB | ||
| 2024-09-23 14:15 |
Major Shareholding Notification
Major Shareholding Notification (LINK) - 13 September 2024 rev
|
English | 494.2 KB | ||
| 2024-09-19 07:00 |
Interim Report
240919_BAI Interims 24 press release_FINAL
|
English | 468.9 KB | ||
| 2024-07-30 12:56 |
Director's Dealing
PDMR Notification - Dr. Joerg Moeller
|
English | 56.6 KB | ||
| 2024-07-03 07:00 |
Board/Management Information
BAI_LEADERSHIP TEAM CHANGE_FINAL_03.07.2024
|
English | 140.6 KB | ||
| 2024-05-02 15:30 |
Post-Annual General Meeting Information
AGM Results 2 May 2024 FINAL
|
English | 129.2 KB | ||
| 2024-05-01 12:37 |
Major Shareholding Notification
Major Holdings Notification (Annex A) ABG-ODY-BAI LIMITED
|
English | 62.7 KB | ||
| 2024-04-23 07:00 |
Regulatory News Service
Business Update 23 April 24 FINAL
|
English | 166.2 KB | ||
| 2024-04-17 07:00 |
Pre-Annual General Meeting Information
BAI_Publication of the Revised Agenda for the 2024 AGM_FINAL_17.04.24
|
English | 69.7 KB | ||
| 2024-04-15 07:00 |
Board/Management Information
BAI_PROPOSED CHANGES TO BOARD COMPOSITION _FINAL_15.04.24
|
English | 168.4 KB |
Automate Your Workflow. Get a real-time feed of all BenevolentAI filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BenevolentAI via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
